Cargando…
Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation
Nobiletin was found to protect against acute myocardial infarction (AMI)‐induced cardiac function decline and myocardial remodeling, although the dose–effect relationship and underlying pathways remained unclear. In the current research, different doses of Nobiletin (7.5, 15 and 30 mg/kg/day) were a...
Autores principales: | Liu, Zumei, Gao, Zhimin, Zeng, Lihuan, Liang, Zhenye, Zheng, Dechong, Wu, Xiaoqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931132/ https://www.ncbi.nlm.nih.gov/pubmed/33660406 http://dx.doi.org/10.1002/prp2.728 |
Ejemplares similares
-
Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019) -
Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α
por: Zhou, Yufei, et al.
Publicado: (2021) -
Impaired Autophagy Contributes to Adverse Cardiac Remodeling in Acute Myocardial Infarction
por: Wu, Xiaoqian, et al.
Publicado: (2014) -
Effects of renal impairment on cardiac remodeling and clinical outcomes after myocardial infarction
por: Chiang, Chun-Yen, et al.
Publicado: (2021) -
Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis
por: Qi, Bingchao, et al.
Publicado: (2022)